Title |
What’s in the pipeline? Drugs in development for autism spectrum disorder
|
---|---|
Published in |
Neuropsychiatric Disease and Treatment, February 2014
|
DOI | 10.2147/ndt.s39516 |
Pubmed ID | |
Authors |
Min Sung, Chee Hon Chin, Choon Guan Lim, Hwee Sen Alvin Liew, Chau Sian Lim, Espérance Kashala, Shih-Jen Weng |
Abstract |
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder with both core symptoms and associated symptoms (eg, irritability, aggression, and comorbidities) that affect both the individual and the family/systems around them. There have been recent advances in the understanding of the underlying pathophysiology of ASD pertaining to genetics, epigenetics, neurological, hormonal, and environmental factors that contribute to the difficulties found in individuals with ASD. With this improved understanding, there has been a shift in the application of psychopharmacology in ASD and its related disorders. A literature review was conducted to examine research published in the last 5 years between different classes of psychotropic medications and ASD. The broad scope of the existing literature for the use of conventional medications is summarized and novel medications are discussed. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 33% |
United States | 1 | 17% |
Unknown | 3 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 67% |
Practitioners (doctors, other healthcare professionals) | 2 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
France | 1 | <1% |
Unknown | 137 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 25 | 18% |
Student > Ph. D. Student | 24 | 17% |
Student > Master | 18 | 13% |
Student > Bachelor | 14 | 10% |
Student > Doctoral Student | 7 | 5% |
Other | 24 | 17% |
Unknown | 27 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 30 | 22% |
Psychology | 27 | 19% |
Agricultural and Biological Sciences | 20 | 14% |
Neuroscience | 7 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
Other | 15 | 11% |
Unknown | 36 | 26% |